Anna Antipov

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Inflammatory Response

Respiratory Syndrome Coronavirus

Saccharomyces Cerevisiae

Top Venues

Journal of veterinary pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro L Sanchez, Greiciely Andre, Anna Antipov, Nikolai Petrovsky, Ted M Ross
Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines. Vaccines 12 (5) (2024)
Pedro L Sanchez, Greiciely Andre, Anna Antipov, Nikolai Petrovsky, Ted M Ross
Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines. Vaccines 12 (5) (2024)
David J McLelland, Michael Lynch, Larry Vogelnest, Paul Eden, Alisa Wallace, Jayne Weller, Sam Young, Rebecca Vaughan-Higgins, Anna Antipov, Yoshikazu Honda-Okubo, Nikolai Petrovsky
Safety and immunogenicity of an adjuvanted recombinant spike protein-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, SpikeVet™, in selected Carnivora, Primates and Artiodactyla in Australian zoos. Journal of veterinary pharmacology and therapeutics 47 (4) (2024)
David J McLelland, Michael Lynch, Larry Vogelnest, Paul Eden, Alisa Wallace, Jayne Weller, Sam Young, Rebecca Vaughan-Higgins, Anna Antipov, Yoshikazu Honda-Okubo, Nikolai Petrovsky
Safety and immunogenicity of an adjuvanted recombinant spike protein-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, SpikeVet™, in selected Carnivora, Primates and Artiodactyla in Australian zoos. Journal of veterinary pharmacology and therapeutics (2024)
Yoshikazu Honda-Okubo, Anna Antipov, Greiciely Andre, Saghar Barati, Hamidreza Kafi, Nikolai Petrovsky
Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variants. Immunology (2023)